Hanarostent Biliary (Nnn)
Payments companies reported to CMS as associated with Hanarostent Biliary (Nnn). "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Hanarostent Biliary (Nnn), per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Hanarostent Biliary (Nnn)
These are the largest totals companies reported as associated with Hanarostent Biliary (Nnn). They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Gregory Haber | New York, NY | Gastroenterology (Internal Medicine) | $3,309.61 |
| Andrew Storm | Winston Salem, NC | Gastroenterology (Internal Medicine) | $1,504.49 |
| Jaroslav Zivny | Worcester, MA | Gastroenterology (Internal Medicine) | $1,500.00 |
| Christopher Marshall | Worcester, MA | Gastroenterology (Internal Medicine) | $1,500.00 |
| Savant Mehta | Worcester, MA | Transplant Hepatology | $1,500.00 |
| Ann Marie Joyce | Acton, MA | Gastroenterology (Internal Medicine) | $1,500.00 |
| Allen L Hwang | Boston, MA | Gastroenterology (Internal Medicine) | $1,500.00 |
| Benjamin Levitzky | Braintree, MA | Gastroenterology (Internal Medicine) | $1,500.00 |
| Christopher Mcgowan | Cary, NC | Gastroenterology (Internal Medicine) | $744.83 |
| Rabindra Watson | West Hollywood, CA | Gastroenterology (Internal Medicine) | $743.97 |
Prescribed Hanarostent Biliary (Nnn)?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.